Smith Anglin Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Sell |
380
-18
| -5% | -$14K | 0.03% | 164 |
|
|
2025
Q1 | $328K | Buy |
398
+4
| +1% | +$3.3K | 0.03% | 154 |
|
|
2024
Q4 | $304K | Sell |
394
-105
| -21% | -$81.1K | 0.03% | 156 |
|
|
2024
Q3 | $443K | Buy |
499
+42
| +9% | +$37.2K | 0.04% | 124 |
|
|
2024
Q2 | $414K | Sell |
457
-34
| -7% | -$30.8K | 0.04% | 120 |
|
|
2024
Q1 | $382K | Sell |
491
-99
| -17% | -$77K | 0.04% | 123 |
|
|
2023
Q4 | $344K | Hold |
590
| – | – | 0.04% | 125 |
|
|
2023
Q3 | $317K | Sell |
590
-152
| -20% | -$81.6K | 0.04% | 128 |
|
|
2023
Q2 | $348K | Sell |
742
-28
| -4% | -$13.1K | 0.04% | 121 |
|
|
2023
Q1 | $264K | Buy |
770
+108
| +16% | +$37.1K | 0.04% | 133 |
|
|
2022
Q4 | $242K | Buy |
662
+34
| +5% | +$12.4K | 0.05% | 123 |
|
|
2022
Q3 | $203K | Buy |
+628
| New | +$203K | 0.04% | 137 |
|